Brussels, Brussels Hoofdstedelijk Gewest, Belgium The fund was located in Europe if to be more exact in Belgium. The main office of represented VC is situated in the Brussels.
The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2015. The top activity for fund was in 2008. The common things for fund are deals in the range of 5 - 10 millions dollars. Opposing the other organizations, this Vinnof works on 0 percentage points less the average amount of lead investments.
Among the most popular portfolio startups of the fund, we may highlight CMOSIS nv, Okapi Sciences, Apitope. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Vinnof, startups are often financed by Capital-E, Vesalius Biocapital Partners, Thuja Capital. The meaningful sponsors for the fund in investment in the same round are Vesalius Biocapital Partners, Gemma Frisius Fund, TrustCapital. In the next rounds fund is usually obtained by Wyvern Seed Fund, Vesalius Biocapital Partners, The Institute for the Promotion of Innovation by Science and Technology in Flanders.
Related Funds
Funds with similar focus
| Fund Name | Location |
| F2Pool | Beijing, Beijing, China |
| Fidelis Capital | Alabama, Birmingham, United States |
| Hammerstone | Arlington, United States, Virginia |
| Mekong Business Initiative | - |
| Optimas Capital Partners Fund | - |
| Pure Consulting | - |
| Rush Enterprises | New Braunfels, Texas, United States |
| Telegraaf Media Groep (TMG) | Amsterdam, Noord-Holland, The Netherlands |
| Total | France, Ile-de-France, Paris |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Loshai | 08 Sep 2022 | Gent, Oost-Vlaanderen, Belgium | |||
Complix | $14M | 26 Jun 2013 | Belgium, Limburg | ||
PharmaDiagnostics | $2M | 14 Oct 2009 | Zellik, Vlaams-Brabant, Belgium | ||
CMOSIS nv | $3M | 10 Aug 2009 | Belgium, Antwerp | ||
Oxynade | $1M | 16 Dec 2008 | Ghent, East Flanders, Belgium | ||
Okapi Sciences | $10M | 03 Nov 2008 | Belgium, Flemish Brabant | ||
Apitope | $11M | 30 Oct 2008 | England | ||
Anygma | $1M | 18 Dec 2007 | Belgium, Antwerp |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Loshai | 08 Sep 2022 | Gent, Oost-Vlaanderen, Belgium | |||
Complix | $14M | 26 Jun 2013 | Belgium, Limburg | ||
PharmaDiagnostics | $2M | 14 Oct 2009 | Zellik, Vlaams-Brabant, Belgium | ||
CMOSIS nv | $3M | 10 Aug 2009 | Belgium, Antwerp | ||
Oxynade | $1M | 16 Dec 2008 | Ghent, East Flanders, Belgium | ||
Okapi Sciences | $10M | 03 Nov 2008 | Belgium, Flemish Brabant | ||
Apitope | $11M | 30 Oct 2008 | England | ||
Anygma | $1M | 18 Dec 2007 | Belgium, Antwerp |
